#BEGIN_DRUGCARD DB03958

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C21H30N10O18P3

# Chemical_IUPAC_Name:
2-amino-9-[(2R,3R,4R,5S)-5-({[({[({[(2S,3R,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]oxy}methyl)-3,4-dihydroxyoxolan-2-yl]-7-methyl-6-oxo-6,9-dihydro-1H-purin-7-ium

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Mrna Cap Analog N7-Methyl Gpppg

# HET_ID:
GTG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C21H29N10O18P3/c1-29-5-31(15-9(29)17(37)28-21(23)26-15)19-13(35)11(33)7(47-19)3-45-51(40,41)49-52(42,43)48-50(38,39)44-2-6-10(32)12(34)18(46-6)30-4-24-8-14(30)25-20(22)27-16(8)36/h4-7,10-13,18-19,32-35H,2-3H2,1H3,(H8-,22,23,25,26,27,28,36,37,38,39,40,41,42,43)/p+1/t6-,7-,10-,11-,12+,13+,18+,19+/m0/s1

# InChI_Key:
InChIKey=FHHZHGZBHYYWTG-RPKOMYRRSA-O

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3958

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
803.4404

# Molecular_Weight_Mono:
803.095238742

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1RI1

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.2

# Predicted_LogS:
-2.3

# Predicted_Water_Solubility:
4.36e+00 g/l

# Primary_Accession_No:
DB03958

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6335949

# PubChem_Substance_ID:
46504811

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01655

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[N+]1=CN([C@@H]2O[C@@H](CO[P@](O)(=O)O[P@](O)(=O)O[P@@](O)(=O)OC[C@@H]3O[C@H]([C@H](O)[C@H]3O)N3C=NC4=C3N=C(N)NC4=O)[C@H](O)[C@H]2O)C2=C1C(=O)NC(N)=N2

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:48 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm. Nucleus

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
DCPS

# Drug_Target_1_GenBank_ID_Gene:
AY040773

# Drug_Target_1_GenBank_ID_Protein:
21654920

# Drug_Target_1_GeneCard_ID:
DCPS

# Drug_Target_1_Gene_Name:
DCPS

# Drug_Target_1_Gene_Sequence:
>1014 bp
ATGGCGGACGCAGCTCCTCAACTAGGCAAGAGGAAGCGCGAATTGGACGTGGAGGAGGCC
CACGCCGCCAGCACAGAGGAAAAGGAGGCAGGAGTTGGAAATGGTACCTGTGCTCCTGTC
CGCTTACCGTTCTCCGGCTTCAGACTGCAGAAGGTGCTGAGGGAGTCTGCGCGGGACAAA
ATCATTTTCCTACACGGGAAGGTGAATGAGGCCTCTGGGGATGGGGATGGAGAGGATGCC
GTTGTGATCCTGGAGAAGACGCCATTTCAGGTGGAACAGGTGGCTCAGCTCCTGACGGGC
AGCCCTGAGCTCCAATTGCAGTTCTCCAATGATATCTACAGCACCTATCACTTGTTCCCT
CCAAGACAACTGAATGATGTAAAGACGACCGTGGTTTACCCTGCCACAGAGAAACACCTG
CAGAAGTACCTGCGCCAGGACCTCCGCCTGATCCGAGAGACGGGAGATGACTACAGGAAT
ATTACTTTACCCCACCTGGAGTCCCAGAGCCTCAGCATCCAGTGGGTGTATAACATTCTC
GACAAGAAGGCTGAAGCGGACCGGATTGTTTTCGAGAACCCAGATCCCTCTGATGGTTTT
GTCCTCATCCCTGACCTCAAGTGGAACCAACAGCAGCTCGATGACTTGTACTTGATCGCC
ATCTGCCATCGCCGGGGCATCAGATCCCTACGCGACCTTACTCCGGAGCACTTGCCGCTG
CTCAGGAACATCCTCCACCAGGGGCAGGAGGCCATCCTGCAGCGCTACCGGATGAAGGGA
GACCATCTGCGAGTATACCTGCACTACCTGCCCTCCTACTACCACCTGCATGTGCACTTC
ACCGCCCTGGGCTTCGAGGCCCCCGGCTCAGGCGTGGAGCGGGCCCACCTGCTGGCTGAG
GTGATCGAGAACTTGGAGTGTGACCCTAGGCACTACCAGCAGCGCACGCTCACCTTCGCC
CTCAGGGCTGACGACCCCCTGCTCAAGCTCTTGCAGGAGGCTCAGCAAAGCTGA

# Drug_Target_1_General_Function:
Involved in mRNA degradation

# Drug_Target_1_General_References:
11042152	Zhang QH, Ye M, Wu XY, Ren SX, Zhao M, Zhao CJ, Fu G, Shen Y, Fan HY, Lu G, Zhong M, Xu XR, Han ZG, Zhang JW, Tao J, Huang QH, Zhou J, Hu GX, Gu J, Chen SJ, Chen Z: Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells. Genome Res. 2000 Oct;10(10):1546-60.
12198172	Liu H, Rodgers ND, Jiao X, Kiledjian M: The scavenger mRNA decapping enzyme DcpS is a member of the HIT family of pyrophosphatases. EMBO J. 2002 Sep 2;21(17):4699-708.
12871939	Kwasnicka DA, Krakowiak A, Thacker C, Brenner C, Vincent SR: Coordinate expression of NADPH-dependent flavin reductase, Fre-1, and Hint-related 7meGMP-directed hydrolase, DCS-1. J Biol Chem. 2003 Oct 3;278(40):39051-8. Epub 2003 Jul 18.

# Drug_Target_1_HGNC_ID:
HGNC:29812

# Drug_Target_1_HPRD_ID:
16787

# Drug_Target_1_ID:
2247

# Drug_Target_1_Locus:
11q24.2

# Drug_Target_1_Molecular_Weight:
38609

# Drug_Target_1_Name:
Scavenger mRNA-decapping enzyme DcpS

# Drug_Target_1_Number_of_Residues:
337

# Drug_Target_1_PDB_ID:
1XMM

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF05652	DcpS

# Drug_Target_1_Protein_Sequence:
>Scavenger mRNA-decapping enzyme DcpS
MADAAPQLGKRKRELDVEEAHAASTEEKEAGVGNGTCAPVRLPFSGFRLQKVLRESARDK
IIFLHGKVNEASGDGDGEDAVVILEKTPFQVEQVAQLLTGSPELQLQFSNDIYSTYHLFP
PRQLNDVKTTVVYPATEKHLQKYLRQDLRLIRETGDDYRNITLPHLESQSLSIQWVYNIL
DKKAEADRIVFENPDPSDGFVLIPDLKWNQQQLDDLYLIAICHRRGIRSLRDLTPEHLPL
LRNILHQGQEAILQRYRMKGDHLRVYLHYLPSYYHLHVHFTALGFEAPGSGVERAHLLAE
VIENLECDPRHYQQRTLTFALRADDPLLKLLQEAQQS

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Necessary for the complete degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay. Removes the 7-methyl guanine cap structure from mRNA fragments shorter than 10 nucleotides that are produced by 3'->5' exosome-mediated mRNA decay. Releases m7GMP. Can also degrade m7GDP to m7GMP. Has no activity towards mRNA molecules longer than 25 nucleotides

# Drug_Target_1_SwissProt_ID:
Q96C86

# Drug_Target_1_SwissProt_Name:
DCPS_HUMAN

# Drug_Target_1_Synonyms:
DCS-1
EC 3.-.-.-
HINT-5
Hint- related 7meGMP-directed hydrolase
Histidine triad protein member 5

# Drug_Target_1_Theoretical_pI:
6.35

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
M24734

# Drug_Target_2_GenBank_ID_Protein:
499864

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
L1

# Drug_Target_2_Gene_Sequence:
>3804 bp
ATGTCATCCATGATACTGACTCAGTTTGGACCGTTCATTGAGAGCATTTCAGGTATCACT
GATCAATCGAATGACGTGTTTGAAGATGCAGCAAAAGCATTCTCTATGTTTACTCGCAGC
GATGTCTACAAGGCGCTGGATGAAATACCTTTCTCTGATGATGCGATGCTTCCAATCCCT
CCAACTATATATACGAAACCATCTCACGATTCATATTATTACATTGATGCTCTAAACCGT
GTGCGTCGCAAAACATATCAGGGCCCTGATGACGTGTACGTACCTAATTGTTCTATTGTT
GAATTGCTGGAGCCACATGAGACTCTGACATCTTATGGGCGGTTGTCCGAGGCCATCGAG
AATCGTGCCAAGGATGGGGACAGCCAAGCCAGAATCGCCACAACGTATGGTAGAATCGCT
GAATCTCAAGCTCGACAGATTAAGGCTCCATTGGAGAAGTTTGTGTTGGCACTATTAGTG
GCCGAAGCAGGGGGGTCTTTATATGATCCAGTTTTGCAGAAGTATGATGAGATTCCAGAT
CTATCGCATAATTGCCCTTTATGGTGTTTTAGAGAGATCTGTCGTCACATATCTGGTCCA
TTACCAGATCGGGCACCTTATCTTTACTTATCTGCAGGGGTATTCTGGTTAATGTCACCA
CGAATGACGTCTGCAATCCCTCCGCTACTATCCGATCTTGTTAATTTAGCTATTTTGCAA
CAAACTGCGGGTTTAGATCCATCATTAGTGAAATTGGGAGTACAGATATGCCTTCATGCA
GCAGCTAGCTCAAGTTATTCATGGTTTATCTTAAAGACTAAGTCTATTTTTCCTCAAAAC
ACGTTGCACAGTATGTATGAATCTCTAGAAGGGGGATACTGTCCTAATCTTGAATGGTTA
GAGCCTAGATCAGACTATAAGTTCATGTACATGGGAGTCATGCCATTGTCCGCTAAGTAT
GCTAGGTCGGCGCCGTCCAATGATAAGAAAGCGCGGGAACTTGGCGAGAAATATGGACTG
AGCTCAGTCGTCGGTGAGCTTCGTAAACGGACAAAGACGTATGTTAAACATGACTTTGCT
TCAGTGAGGTACATTCGTGACGCTATGGCATGTACTAGCGGTATTTTCTTGGTAAGAACA
CCCACCGAAACGGTATTGCAAGAATATACGCAGAGTCCGGAGATTAAGGTTCCCATTCCC
CAGAAAGACTGGACAGGCCCAATAGGTGAAATCAGAATTCTAAAAGATACAACAAGTTCC
ATCGCGCGTTACTTATATAGAACATGGTACTTGGCAGCGGCGAGAATGGCGGCTCAACCA
CGTACGTGGGATCCATTGTTTCAAGCGATTATGAGATCTCAATACGTGACAGCTAGGGGT
GGATCTGGCGCAGCACTCCGCGAATCTTTGTATGCAATCAATGTGTCGTTACCTGATTTC
AAGGGCTTACCAGTGAAGGCAGCAACTAAGATATTCCAGGCGGCACAATTAGCGAACTTG
CCGTTCTCCCACACATCAGTGGCTATACTAGCTGACACTTCAATGGGATTGCGAAATCAG
GTGCAGAGGCGGCCACGATCCATTATGCCATTAAATGTGCCCCAGCAGCAGGTTTCGGCG
CCCCATACATTGACAGCGGATTACATTAACTACCACATGAATCTATCACCCACGTCTGGT
AGTGCGGTCATTGAGAAGGTGATTCCTTTAGGTGTATACGCTTCGAGCCCTCCTAACCAG
TCGATCAACATTGACATATCTGCGTGTGACGCTAGTATTACTTGGGATTTCTTTCTGTCA
GTGATTATGGCGGCTATACACGAAGGTGTCGCTAGTAGCTCCATTGGAAAACCATTTATG
GGGGTTCCTGCATCCATTGTAAATGATGAGTCTGTCGTTGGAGTGAGAGCTGCTAGGCCG
ATATCGGGAATGCAGAACATGATTCAGCATCTATCGAAACTATATAAACGTGGATTTTCA
TATAGAGTAAACGATTCTTTTTCTCCAGGTAACGATTTTACTCATATGACTACCACTTTC
CCGTCAGGTTCAACAGCCACCTCTACTGAGCATACTGCTAATAATAGTACGATGATGGAA
ACTTTCCTGACAGTATGGGGACCCGAACATACTGACGACCCTGACGTCTTACGTTTAATG
AAGTCTTTAACTATTCAAAGGAATTACGTATGTCAAGGTGATGATGGATTAATGATTATC
GATGGGACTACTGCTGGTAAGGTGAACAGTGAAACTATTCAGAACGATCTAGAATTAATC
TCAAAATATGGTGAGGAATTCGGATGGAAATATGACATAGCGTACGATGGGACTGCCGAA
TACTTAAAGCTATACTTCATATTTGGCTGTCGAATTCCAAATCTTAGTCGCCATCCAATC
GTGGGGAAAGAACGGGCGAATTCTTCAGCAGAGGAGCCATGGCCAGCAATTCTAGATCAG
ATTATGGGTGTCTTCTTTAATGGTGTTCATGATGGGTTACAGTGGCAGCGGTGGATACGT
TATTCATGGGCTCTATGCTGTGCTTTCTCACGTCAAAGAACAATGATTGGTGAGAGCGTG
GGTTACCTTCAATATCCTATGTGGTCTTTTGTCTACTGGGGATTACCACTGGTTAAAGCG
TTTGGGTCAGACCCATGGATATTTTCTTGGTACATGCCTACTGGAGATCTGGGAATGTAT
AGTTGGATTAGCTTGATACGCCCTCTGATGACAAGATGGATGGTGGCTAATGGTTACGTA
ACTGACAGATGCTCAACCGTATTCGGGAACGCAGATTATCGCAGGTGTTTCAATGAACTT
AAACTATATCAAGGTTATTATATGGCACAATTGCCCAGGAATCCTAAGAAGTCTGGACGA
GCGGCCTCTCGGGAGGTAAGAGAACAATTCACTCAGGCATTATCCGACTATCTAATGCAA
AATCCAGAGCTGAAGTCACGTGTGCTACGTGGTCGTAGTGAGTGGGAGAAATATGGAGCG
GGGATAATTCACAATCCTCCGTCATTATTCGATGTGCCCCATAAATGGTATCAGGGTGCG
CAAGAGGCAGCAATCGCTACGAGAGAAGAGCTGGCAGAAATGGATGAGACATTAATGCGC
GCTCGAAGGCACAGCTATTCGAGCTTTTCAAAGTTATTAGAGGCGTATCTGCTCGTGAAA
TGGCGAATGTGCGAGGCCCGCGAACCGTCGGTTGATTTGCGATTACCATTATGTGCGGGT
ATTGACCCATTAAACTCAGATCCTTTTCTCAAGATGGTAAGCGTTGGACCAATGCTCCAG
AGTACGAGAAAGTACTTTGCTCAGACACTATTCATGGCAAAGACGGTGTCGGGTCTTGAC
GTTAACGCGATTGATAGCGCGTTATTACGACTGCGAACATTAGGTGCTGATAAGAAAGCA
TTAACGGCGCAGTTATTAATGGTGGGGCTTCAGGAGTCAGAAGCGGACGCATTGGCCGGG
AAGATAATGCTACAGGATGTGAATACTGTGCAATTAGCCAGAGTGGTTAACTTAGCTGTG
CCAGATACTTGGATGTCGTTAGACTTTGACTCTATGTTCAAACACCACGTCAAGCTGCTT
CCCAAAGATGGACGTCATCTAAATACTGATATTCCTCCTCGAATGGGATGGTTACGGGCC
ATTTTACGATTCTTAGGTGCCGGAATGGTAATGACTGCGACTGGAGTTGCTGTCGACATC
TATCTGGAGGATATACATGGCGGTGGTCGGTCACTTGGACAGAGATTCATGACTTGGATG
CGACAGGAAGGACGGTCAGCGTGA

# Drug_Target_2_General_Function:
Involved in RNA binding

# Drug_Target_2_General_References:
2922925	Wiener JR, Joklik WK: The sequences of the reovirus serotype 1, 2, and 3 L1 genome segments and analysis of the mode of divergence of the reovirus serotypes. Virology. 1989 Mar;169(1):194-203.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3130

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
142272

# Drug_Target_2_Name:
Minor core protein lambda-3

# Drug_Target_2_Number_of_Residues:
1267

# Drug_Target_2_PDB_ID:
1UON

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF07925	RdRP_5

# Drug_Target_2_Protein_Sequence:
>Minor core protein lambda-3
MSSMILTQFGPFIESISGITDQSNDVFEDAAKAFSMFTRSDVYKALDEIPFSDDAMLPIP
PTIYTKPSHDSYYYIDALNRVRRKTYQGPDDVYVPNCSIVELLEPHETLTSYGRLSEAIE
NRAKDGDSQARIATTYGRIAESQARQIKAPLEKFVLALLVAEAGGSLYDPVLQKYDEIPD
LSHNCPLWCFREICRHISGPLPDRAPYLYLSAGVFWLMSPRMTSAIPPLLSDLVNLAILQ
QTAGLDPSLVKLGVQICLHAAASSSYSWFILKTKSIFPQNTLHSMYESLEGGYCPNLEWL
EPRSDYKFMYMGVMPLSAKYARSAPSNDKKARELGEKYGLSSVVGELRKRTKTYVKHDFA
SVRYIRDAMACTSGIFLVRTPTETVLQEYTQSPEIKVPIPQKDWTGPIGEIRILKDTTSS
IARYLYRTWYLAAARMAAQPRTWDPLFQAIMRSQYVTARGGSGAALRESLYAINVSLPDF
KGLPVKAATKIFQAAQLANLPFSHTSVAILADTSMGLRNQVQRRPRSIMPLNVPQQQVSA
PHTLTADYINYHMNLSPTSGSAVIEKVIPLGVYASSPPNQSINIDISACDASITWDFFLS
VIMAAIHEGVASSSIGKPFMGVPASIVNDESVVGVRAARPISGMQNMIQHLSKLYKRGFS
YRVNDSFSPGNDFTHMTTTFPSGSTATSTEHTANNSTMMETFLTVWGPEHTDDPDVLRLM
KSLTIQRNYVCQGDDGLMIIDGTTAGKVNSETIQNDLELISKYGEEFGWKYDIAYDGTAE
YLKLYFIFGCRIPNLSRHPIVGKERANSSAEEPWPAILDQIMGVFFNGVHDGLQWQRWIR
YSWALCCAFSRQRTMIGESVGYLQYPMWSFVYWGLPLVKAFGSDPWIFSWYMPTGDLGMY
SWISLIRPLMTRWMVANGYVTDRCSTVFGNADYRRCFNELKLYQGYYMAQLPRNPKKSGR
AASREVREQFTQALSDYLMQNPELKSRVLRGRSEWEKYGAGIIHNPPSLFDVPHKWYQGA
QEAAIATREELAEMDETLMRARRHSYSSFSKLLEAYLLVKWRMCEAREPSVDLRLPLCAG
IDPLNSDPFLKMVSVGPMLQSTRKYFAQTLFMAKTVSGLDVNAIDSALLRLRTLGADKKA
LTAQLLMVGLQESEADALAGKIMLQDVNTVQLARVVNLAVPDTWMSLDFDSMFKHHVKLL
PKDGRHLNTDIPPRMGWLRAILRFLGAGMVMTATGVAVDIYLEDIHGGGRSLGQRFMTWM
RQEGRSA

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
P17378

# Drug_Target_2_SwissProt_Name:
RDRP_REOVD

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
8.02

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB03958
